Xin Lu

29PUBLICATIONS
105CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsInnate immunityPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 22, 2026
The rise of reducing reagent-resistant TfR1 dimer marks ferroptosis.

|Jul 01, 2026
Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.

|Jun 16, 2026
Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

|Dec 03, 2025
CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer.

Guoqiang Liu, Shiyu Wang, Loan Duong

|Nov 24, 2025
An oncogenotype-immunophenotype paradigm governing the myeloid landscape in genetically engineered mouse models of prostate cancer.

Yuting Zhang, Yaoyin Li, Dailin Gan

|Sep 13, 2025
Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary Cancers.

Firas Hatoum, Adnan Fazili, Justin W Miller

Pageof 5

Frequent Collaborators

4 joint publications

Dailin Gan

3 joint publications

Jianping He

3 joint publications

Zachary T Schafer

3 joint publications

Jun Wan